
NASDAQHealthcareMedical - Instruments & Supplies
أحدث البيانات المتاحة
80.69 US$
+1.05 US$ · +1.32%
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
الإغلاق السابق
80.69 US$
+1.05 US$ · +1.32%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
نطاق اليوم
السعر الحالي 80.69 US$
نطاق 52 أسبوعًا
السعر الحالي 80.69 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
71
أقل من القيمة
المشاعر
71
صعودي
المخاطر
31
مخاطر متوسطة
الزخم
60
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
نطاق اليوم
السعر الحالي 80.69 US$
نطاق 52 أسبوعًا
السعر الحالي 80.69 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 249.6 مليون USD | 219.86 مليون USD | 193.48 مليون USD | 161.65 مليون USD | 154.42 مليون USD |
| تكلفة البضاعة المباعة | 71.06 مليون USD | 68.96 مليون USD | 66.44 مليون USD | 56.76 مليون USD | 53.04 مليون USD |
| الربح الإجمالي | 178.54 مليون USD | 150.9 مليون USD | 127.05 مليون USD | 104.9 مليون USD | 101.38 مليون USD |
| البحث والتطوير | 14.14 مليون USD | 15.65 مليون USD | 16.97 مليون USD | 13.29 مليون USD | 11.8 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 96.49 مليون USD | 83 مليون USD | 72.89 مليون USD | 61.67 مليون USD | 53.16 مليون USD |
| نفقات التشغيل | 110.63 مليون USD | 98.65 مليون USD | 90.34 مليون USD | 78.07 مليون USD | 64.96 مليون USD |
| دخل الفوائد | 13.09 مليون USD | 4.95 مليون USD | 3.08 مليون USD | 986 ألف USD | 197 ألف USD |
| مصاريف الفوائد | 5.18 مليون USD | 205 ألف USD | — | — | 2.22 مليون USD |
| الاستهلاك والإطفاء | 10.42 مليون USD | 9.67 مليون USD | 9.52 مليون USD | 9.43 مليون USD | 11.07 مليون USD |
| الدخل التشغيلي | 67.91 مليون USD | 52.26 مليون USD | 36.71 مليون USD | 26.83 مليون USD | 36.43 مليون USD |
| صافي الدخل | 57.73 مليون USD | 44.04 مليون USD | 30.11 مليون USD | 20.64 مليون USD | 26.91 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
115 US$
ارتفاع محتمل بنسبة 42.52%صناديق متداولة تفصح عن تعرضها لهذا السهم.
iShares Core S&P Small-Cap ETFIJR101.13 مليون0.10%103.19 مليار USD0.06%137.55 US$+0.17%
First Trust SMID Cap Rising Dividend Achievers ETFSDVY85.25 مليون0.78%10.92 مليار USD0.58%41.24 US$+0.05%
Vanguard Morningstar Total Stock Market ETFVTI55.68 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH50.9 مليون0.22%145.5 مليون USD0.25%49.85 US$+0.02%
iShares Russell 2000 ETFIWM45.59 مليون0.06%78.74 مليار USD0.19%278.94 US$+0.49%
Vanguard Extended Market ETFVXF19.56 مليون0.02%95.4 مليار USD0.05%235 US$+0.80%
Guggenheim Funds Trust - Guggenheim Securitized Income ETFGISC16.97 مليون0.23%67.9 مليون USD0.47%49.2511 US$+0.08%
iShares Russell 2000 Growth ETFIWO16.08 مليون0.12%13.92 مليار USD0.24%356.78 US$+0.94%
iShares Core S&P Small-Cap ETFIJR
First Trust SMID Cap Rising Dividend Achievers ETFSDVY
Vanguard Morningstar Total Stock Market ETFVTI
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Guggenheim Funds Trust - Guggenheim Securitized Income ETFGISC
iShares Russell 2000 Growth ETFIWOالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.